Brian Koopman's Insider Trades & SAST Disclosures
Brian Koopman's most recent trade in Utah Medical Products, Inc. was a trade of 500 Employee Stock Option - Right to Buy done . Disclosure was reported to the exchange on Nov. 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian Koopman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Utah Medical Products, Inc. | Brian L. Koopman | Principal Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 500 | 5,100 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian L. Koopman | Principal Financial Officer | Gift of securities by or to the insider at price $ 71.62 per share. | 18 Jul 2024 | 50 | 882 (0%) | 0% | 71.6 | 3,581 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 500 | 4,600 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Gift of securities by or to the insider at price $ 94.32 per share. | 15 Jun 2023 | 60 | 932 (0%) | 0% | 94.3 | 5,659 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 500 | 4,100 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.64 per share. | 06 Dec 2022 | 500 | 992 (0%) | 0% | 74.6 | 37,320 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.88 per share. | 06 Dec 2022 | 366 | 492 (0%) | 0% | 101.9 | 37,288 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Gift of securities by or to the insider at price $ 88.94 per share. | 31 Oct 2022 | 65 | 858 (0%) | 0% | 88.9 | 5,781 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 1,000 | 4,600 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.50 per share. | 27 Oct 2021 | 687 | 923 (0%) | 0% | 58.5 | 40,190 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 687 | 3,600 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.62 per share. | 27 Oct 2021 | 433 | 174 (0%) | 0% | 99.6 | 43,135 | Common Stock |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 62 | 3,600 | - | - | Employee Stock Option - Right to Buy | |
| Utah Medical Products, Inc. | Brian Koopman | Principal Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.18 per share. | 27 Oct 2021 | 62 | 236 (0%) | 0% | 49.2 | 3,049 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges